160
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics

, , , , , & show all
Pages 96-104 | Received 25 May 2018, Accepted 06 Sep 2018, Published online: 26 Sep 2018

References

  • Huang H-J, Lin C-C, Chou H-C. Proteomic analysis of Rhein-induced cyt: ER stress mediates cell death in breast cancer cells. Mol Biosyst. 2014;10:3086–3100.
  • Yuan Y-F, Hu X-Y, He Y, et al. Synthesis and anti-tumor activity evaluation of Rhein-aloe emodin hybrid molecule. Nat Prod Commun. 2012;7:207–210.
  • Zhou YX, Xia W, Yue W, et al. Rhein: a review of pharmacological activities. Evid Based Complement Alternat Med. 2015;2015:1.
  • Hu G, Liu J, Zhen YZ, et al. Rhein inhibits the expression of vascular cell adhesion molecule 1 in human umbilical vein endothelial cells with or without lipopolysaccharide stimulation. Am J Chin Med. 2013;41:473–485.
  • Gomez-Gaete C, Retamal M, Chavez C, et al. Development, characterization and in vitro evaluation of biodegradable Rhein-loaded microparticles for treatment of osteoarthritis. Eur J Pharm Sci. 2017;96:390–397.
  • Azelmat J, Larente JF, Grenier D. The anthraquinone Rhein exhibits synergistic antibacterial activity in association with metronidazole or natural compounds and attenuates virulence gene expression in Porphyromonas gingivalis. Arch Oral Biol. 2015;60:342–346.
  • Zhang Q, Liu L, Lin W, et al. Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease. Kidney Int. 2017;91:144–156.
  • Zeng C-C, Liu X, Chen G-R, et al. The molecular mechanism of Rhein in diabetic nephropathy. Evid Based Complement Alternat Med. 2014;2014:1.
  • Sun H, Luo G, Chen D, et al. A comprehensive and system review for the pharmacological mechanism of action of Rhein, an active anthraquinone ingredient. Front Pharmacol. 2016;7:247
  • Yuan Z, Gu X. Preparation, characterization, and in vivo study of Rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery. Drug Des Devel Ther. 2015;9:2301–2309.
  • Cong X-D, Fu P-R, Dai D-Z, et al. Pharmacokinetic behavior of argirein, derived from Rhein, is characterized as slow release and prolonged T-1/2 of Rhein in rats. Eur J Pharm Sci. 2012;46:468–474.
  • Lv P, Liu M, Liao R, et al. Host-guest inclusion system of Rhein with polyamine-modified beta-cyclodextrins: characterization and cytotoxicity. Pharm Dev Technol. 2017;22:669–677.
  • Suneela D, Dipmala P. Synthesis and pharmacokinetic profile of Rhein-boswellic acid conjugate. Bioorg Med Chem Lett. 2012;22:7582–7587.
  • Dhaneshwar S, Dipmala P, Abhay H, et al. Disease-modifying effect of anthraquinone prodrug with boswellic acid on collagenase-induced osteoarthritis in Wistar rats. IADT. 2013;12:288–295.
  • Fox ME, Szoka FC, Fréchet JMJ. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res. 2009;42:1141–1151.
  • He R, Yin C. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel. Acta Biomater. 2017;53:355–366.
  • Lu B, Huang D, Zheng H, et al. Preparation, characterization, and in vitro efficacy of O-carboxymethyl chitosan conjugate of melphalan. Carbohydr Polym. 2013;98:36–42.
  • Lawrence PB, Billings WM, Miller MB, et al. Conjugation strategy strongly impacts the conformational stability of a PEG-protein conjugate. ACS Chem Biol. 2016;11:1805–1809.
  • Yin S, Huai J, Chen X, et al. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Acta Biomater. 2015;26:274–285.
  • Bao X, Wang W, Wang C, et al. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy. Biomaterials. 2014;35:8450–8466.
  • Dey S, Sreenivasan K. Conjugation of curcumin onto alginate enhances aqueous solubility and stability of curcumin. Carbohydr Polym. 2014;99:499–507.
  • Amin M, Abbas NS, Hussain MA, et al. Cellulose ether derivatives: a new platform for prodrug formation of fluoroquinolone antibiotics. Cellulose. 2015;22:2011–2022.
  • Abbas NS, Amin M, Hussain MA, et al. Extended release and enhanced bioavailability of moxifloxacin conjugated with hydrophilic cellulose ethers. Carbohydr Polym. 2016;136:1297–1306.
  • Park JH, Saravanakumar G, Kim K, et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. 2010;62:28–41.
  • Thotakura N, Dadarwal M, Kumar P, et al. Chitosan-stearic acid based polymeric micelles for the effective delivery of tamoxifen: cytotoxic and pharmacokinetic evaluation. Aaps Pharmscitech. 2017;18:759–768.
  • Ahmed S, Sheraz MA, Rehman IU. Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight. Aaps Pharmscitech. 2013;14:870–879.
  • Park JK, Chung MJ, Choi HN, et al. Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity. IJMS. 2011;12:266–277.
  • Jeong K-J, Song Y, Shin H-R, et al. In vivo study on the biocompatibility of chitosan-hydroxyapatite film depending on degree of deacetylation. J Biomed Mater Res. 2017;105:1637–1645.
  • He X-K, Yuan Z-X, Wu X-J, et al. Low molecular weight hydroxyethyl chitosan-prednisolone conjugate for renal targeting therapy: synthesis, characterization and in vivo studies. Theranostics. 2012;2:1054–1063.
  • Ahn S, Lee I-H, Lee E, et al. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan. J Control Release. 2013;170:226–232.
  • Yuan Z-X, Li J-J, Zhu D, et al. Enhanced accumulation of low-molecular-weight chitosan in kidneys: a study on the influence of N-acetylation of chitosan on the renal targeting. J Drug Targeting. 2011;19:540–551.
  • Liu Y, Sun Y, He S, et al. Synthesis and characterization of gibberellin-chitosan conjugate for controlled-release applications. Int J Biol Macromol. 2013;57:213–217.
  • Ding Y, Zhang P, Tang X-Y, et al. PEG prodrug of gambogic acid: amino acid and dipeptide spacer effects. Polymer 2012;53:1694–1702.
  • Yuan Z-X, Sun X, Gong T, et al. Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier. J Drug Target. 2007;15:269–278.
  • Singh VK, Subudhi BB. Development and characterization of lysine-methotrexate conjugate for enhanced brain delivery. Drug Deliv. 2016;23:2327–2337.
  • Sun HT, Chang MYZ, Cheng WI, et al. Biodegradable zwitterionic sulfobetaine polymer and its conjugate with paclitaxel for sustained drug delivery. Acta Biomater. 2017;64:290–300.
  • Ma L, Chen Y, Wang X, et al. Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan. Bioorg Med Chem Lett. 2018; 28:2920–2924.
  • Zhang Y, Song H, Shang Z, et al. Amino acid-PEGylated resveratrol and its influence on solubility and the controlled release behavior. Biol Pharm Bull. 2014;37:785–793.
  • Raja MA, Shah Z, Arif M, et al. Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery. IJN. 2016;11:4397–4412.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.